178 related articles for article (PubMed ID: 3523025)
1. [Rhabdomyosarcoma: morphology and cellular differentiation].
Schmidt D; Harms D; Reimann O; Treuner J
Klin Padiatr; 1986; 198(3):202-7. PubMed ID: 3523025
[TBL] [Abstract][Full Text] [Related]
2. Cellular differentiation and prognosis in embryonal rhabdomyosarcoma. A report from the Cooperative Soft Tissue Sarcoma Study 1981 (CWS 81).
Schmidt D; Reimann O; Treuner J; Harms D
Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):183-94. PubMed ID: 3012860
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
Furlong MA; Fanburg-Smith JC
Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
[TBL] [Abstract][Full Text] [Related]
4. Therapy associated differentiation in rhabdomyosarcomas.
d'Amore ES; Tollot M; Stracca-Pansa V; Menegon A; Meli S; Carli M; Ninfo V
Mod Pathol; 1994 Jan; 7(1):69-75. PubMed ID: 8159655
[TBL] [Abstract][Full Text] [Related]
5. The applicability of immunohistochemistry in the diagnosis and differential diagnosis of malignant soft tissue tumors. A reevaluation based on the material of the Kiel Pediatric Tumor Registry.
Schmidt D; Harms D
Klin Padiatr; 1990; 202(4):224-9. PubMed ID: 2168499
[TBL] [Abstract][Full Text] [Related]
6. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
Harms D
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyosarcoma in childhood. An immunohistological analysis with myoglobin, desmin and vimentin.
Kodet R
Pathol Res Pract; 1989 Aug; 185(2):207-13. PubMed ID: 2798221
[TBL] [Abstract][Full Text] [Related]
8. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis.
Coffin CM; Rulon J; Smith L; Bruggers C; White FV
Mod Pathol; 1997 Dec; 10(12):1175-87. PubMed ID: 9436961
[TBL] [Abstract][Full Text] [Related]
9. [Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology].
Treuner J; Kaatsch P; Anger Y; Seipp A; Spaar HJ; Gerein V; Suder J; Niethammer D
Klin Padiatr; 1986; 198(3):208-17. PubMed ID: 3523026
[TBL] [Abstract][Full Text] [Related]
10. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic analysis of spindle cell rhabdomyosarcoma: report of 8 cases].
Zhang HT; Guo L; Su Q
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):141-3. PubMed ID: 18646700
[TBL] [Abstract][Full Text] [Related]
12. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
Smith LM; Anderson JR; Coffin CM
Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
[TBL] [Abstract][Full Text] [Related]
13. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
Seidal T; Kindblom LG; Angervall L
Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
[TBL] [Abstract][Full Text] [Related]
14. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
Yun K
Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
[TBL] [Abstract][Full Text] [Related]
15. Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors.
Denk H; Krepler R; Artlieb U; Gabbiani G; Rungger-Brändle E; Leoncini P; Franke WW
Am J Pathol; 1983 Feb; 110(2):193-208. PubMed ID: 6824065
[TBL] [Abstract][Full Text] [Related]
16. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
[TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyosarcoma and extraosseous Ewing's sarcoma].
Harms D; Leuschner I; Krams M; Pilgrim TB; Treuner J
Verh Dtsch Ges Pathol; 1998; 82():83-98. PubMed ID: 10095421
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
Furlong MA; Mentzel T; Fanburg-Smith JC
Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)].
Suder J; Stienen U; Kaatsch P; Harms D; Schmidt D; Spaar HJ; Treuner J
Klin Padiatr; 1986; 198(3):218-23. PubMed ID: 3523027
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
